CCL18 and idiopathic pulmonary fibrosis: A previous study reported that Chemokine C–C motif ligand 2 (CCL18), which was enriched in the inflammatory response, was significantly differentially expressed in COP patients compared to the IPF group [26], indicating a vital role of inflammatory response in COP and IPF.